查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1864487

生物樣本採集試劑盒市場（按樣本類型、最終用戶、產品類型和應用分類）－2025-2032年全球預測

Biological Sample Collection Kits Market by Sample Type, End User, Product Type, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物樣本採集試劑盒市場規模將達到 183.6 億美元，複合年成長率為 8.85%。

主要市場統計數據
基準年 2024 93.1億美元
預計年份：2025年 101.5億美元
預測年份：2032年 183.6億美元
複合年成長率 (%) 8.85%

為決策者提供關於塑造生物樣本採集試劑盒生態系統的新臨床和操作技術要務的全面報告

生物樣本採集生態系處於臨床照護、生命科學研究和分散式醫療服務交會點，要求各利益相關者在科學嚴謹性和操作實用性之間取得平衡。檢測靈敏度的提高、以患者為中心的檢測模式以及自動化程度的提高，都在推動著採集設備的技術需求，同時也提高了用戶體驗、監管鏈完整性和運輸途中樣本穩定性方面的期望。因此，製造商、檢查室管理人員和採購團隊在評估採集解決方案時，不僅要考慮其與下游工作流程的兼容性，還要考慮其降低分析前變異性和操作摩擦的能力。

變革性趨勢正在重塑試劑盒設計、分散式檢查、供應鏈韌性以及監管預期，這要求各相關人員進行策略調整。

生物樣本採集試劑盒領域正經歷變革性的轉變，這主要受技術創新、醫療服務模式轉變以及監管要求日益嚴格的推動。首先，檢測靈敏度的提高和分子診斷技術的廣泛應用，對樣本保存和完整性提出了更高的技術要求，迫使製造商加強對試劑穩定性、容器材料改進以及運輸耐受性設計的投入。這些創新使得分散式檢查得以更廣泛地進行，同時又能確保高複雜度檢測的分析可靠性。

2025年美國關稅調整的累積影響：供應鏈韌性、到岸成本、海關複雜性以及價值鏈中的策略性製造重組

2025年推出調整的關稅及貿易政策變化正從多個面向影響生物樣本採集試劑盒的價值鏈，進而影響採購選擇、到岸成本和策略性生產決策。某些醫療設備類別進口關稅的提高或重新分類，迫使先前依賴成本效益高的跨境採購模式的製造商重新評估供應商合約和總到岸成本。為此，各組織正在加快尋找替代供應商、重新定價商業契約，並在某些情況下擴大本國或周邊地區的產能，以提高可預測性並降低受貿易政策波動的影響。

以細分市場為導向的洞察：解釋樣本類型、不同終端使用者、不同產品類型和各種應用情境的細微差別如何導致差異化的產品策略和商業化方案。

了解生物樣本採集試劑盒市場的詳細情形對於確定產品優先順序、最佳化市場推廣策略以及集中研發投資至關重要。根據樣本類型，該市場可分為血液、唾液、糞便、組織和尿液。血液可細分為血漿、血清和全血，而組織則分為福馬林固定石蠟包埋（FFPE）組織、新鮮組織和冷凍組織。這些區分至關重要，因為不同類型的樣本所需的保存化學方法、容器設計和下游處理要求差異顯著。因此，製造商分別針對核酸、蛋白質和活細胞開發了專用的底物和穩定化方法。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 透過將智慧型手機條碼管理和即時追蹤功能整合到樣本採集包中，加強儲存管理
  • 偏遠地區照護現場診斷應用對非侵入式唾液和呼吸採樣試劑盒的需求日益成長
  • 開發常溫試劑和運輸介質簡化了全球樣品物流，並減少了對低溫運輸的依賴。
  • 利用模組化微流體平台在採集點進行多重生物標記分離與穩定化，此平台適用於採集試劑盒
  • 在出貨前的預分析過程中，利用人工智慧演算法進行品管，以檢測樣品污染或不足情況。
  • 擴大家用DIY基因檢測套組，簡化使用者介面並整合電子商務補充裝選項

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 生物樣本採集試劑盒市場（依樣本類型分類）

  • 血
    • 電漿
    • 血清
    • 全血
  • 唾液
  • 航班
  • 組織
    • FFPE組織
    • 新鮮紙巾
    • 冷凍組織
  • 尿

9. 依最終用戶分類的生物樣本採集試劑盒市場

  • 生物製藥公司
  • 診斷實驗室
  • 居家醫療
  • 醫院
  • 研究所

第10章 生物樣本採集試劑盒市場（按產品類型分類）

  • 自動化系統
  • 多樣本試劑盒
  • 免洗套裝

第11章 生物樣本採集試劑盒市場（按應用領域分類）

  • 臨床診斷
  • 藥物發現
  • 環境監測
  • 基因檢測
  • 傳染病檢查

第12章 生物樣本採集試劑盒市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 生物樣本採集試劑盒市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國生物檢體採集試劑盒市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Becton Dickinson and Company
    • Abbott Laboratories
    • F. Hoffmann-La Roche AG
    • bioMerieux SA
    • Qiagen NV
    • Greiner Bio-One International GmbH
    • Copan Diagnostics Inc.
    • PerkinElmer, Inc.
Product Code: MRR-F97DD5A7DF04

The Biological Sample Collection Kits Market is projected to grow by USD 18.36 billion at a CAGR of 8.85% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 9.31 billion
Estimated Year [2025] USD 10.15 billion
Forecast Year [2032] USD 18.36 billion
CAGR (%) 8.85%

Comprehensive introduction framing the emerging clinical, operational, and technological imperatives that are shaping the biological sample collection kits ecosystem for decision makers

The biological sample collection kits ecosystem sits at the intersection of clinical care, life sciences research, and decentralized health delivery, requiring stakeholders to reconcile scientific rigor with operational practicality. Advances in assay sensitivity, patient-centric testing models, and automation have increased the technical demands placed on collection devices while simultaneously raising expectations for user experience, chain-of-custody integrity, and sample stability during transport. As a result, manufacturers, laboratory directors, and procurement teams must evaluate collection solutions not only for compatibility with downstream workflows but also for their ability to reduce pre-analytical variability and operational friction.

Operational imperatives now include supply reliability, regulatory compliance across jurisdictions, and demonstrable quality systems that support traceability from collection through analysis. These imperatives are complemented by technology trends such as integrated barcoding, ambient-stable preservatives, and modular kit designs that support both centralized and decentralized testing models. As stakeholders navigate this evolving environment, they must balance the need for flexible kit formats with stringent biosafety and data integrity requirements.

This introduction frames the strategic questions that industry leaders face: how to prioritize investments in product development, where to focus partnerships and distribution efforts, and which operational changes will deliver measurable improvements in sample quality and throughput. By understanding these priorities, decision-makers can better align their product roadmaps, procurement strategies, and regulatory engagement to meet the twin goals of scientific fidelity and scalable delivery.

Transformational trends reshaping kit design, decentralised testing, supply chain resilience, and regulatory expectations that demand strategic realignment across stakeholders

The landscape for biological sample collection kits is undergoing transformative shifts driven by technological innovation, changing care delivery models, and heightened regulatory expectations. First, advances in assay sensitivity and the proliferation of molecular diagnostics have elevated the technical requirements for sample preservation and integrity, prompting manufacturers to invest in stabilizing reagents, improved container materials, and transport-robust designs. These innovations are enabling a broader range of decentralized testing while maintaining analytical confidence for high-complexity assays.

Second, patient centricity is reshaping product form factors and user instructions. Remote sample collection and home-based diagnostics are increasing demand for intuitive kit interfaces, simplified instructions for self-collection, and integrated digital support such as mobile-guided workflows and real-time tracking. This trend is causing cross-functional coordination between human factors engineering, regulatory affairs, and digital product teams to ensure both usability and compliance.

Third, supply chain resilience has become a strategic priority as stakeholders reassess single-supplier dependencies, packaging constraints, and temperature-controlled logistics. Companies are responding by diversifying supplier bases, qualifying alternative materials, and investing in regional manufacturing capabilities. Lastly, regulatory scrutiny has intensified around traceability, labeling, and biosafety, encouraging vendors to strengthen quality systems and documentation to expedite approvals and sustain market access. Collectively, these shifts are accelerating the convergence of digital, material science, and operational capabilities within the collection kit sector.

Cumulative effects of 2025 United States tariff adjustments on supply chain resilience, landed costs, customs complexity, and strategic manufacturing redesign across the value chain

Policy changes in tariff schedules and trade measures introduced or adjusted in 2025 have created a multi-dimensional impact on the biological sample collection kits value chain, influencing sourcing choices, landed costs, and strategic manufacturing decisions. When import duties are raised or reclassified for specific medical device categories, manufacturers that previously relied on a cost-efficient cross-border procurement model face immediate pressure to re-evaluate supplier contracts and total landed cost calculations. In response, organizations have accelerated qualification of alternate suppliers, re-priced commercial agreements, and in some cases advanced onshore or nearshore capacity to improve predictability and reduce exposure to trade policy volatility.

Beyond direct cost implications, tariff changes often ripple into logistics and compliance workloads. Increased customs scrutiny requires more granular classification of kit components, more extensive documentation, and tighter coordination with customs brokers and freight forwarders. These administrative burdens can lengthen lead times and create inventory planning challenges, particularly for kits that include temperature-sensitive reagents or specialized consumables. As a consequence, procurement teams are prioritizing suppliers that demonstrate robust customs compliance capabilities and the operational agility to buffer short-term disruptions.

Strategically, tariff-induced pressures are accelerating broader supply chain redesigns. Some organizations are evaluating localized manufacturing to preserve margin and reduce risk, while others are leveraging bonded warehousing, tariff engineering strategies, and trade agreements to mitigate incremental costs. Finally, policy shifts in 2025 have prompted greater emphasis on contractual flexibility, scenario planning, and cross-functional playbooks that align procurement, legal, quality, and commercial teams to respond quickly to evolving trade environments. These measures collectively aim to preserve continuity of supply and protect product affordability without compromising sample integrity or regulatory compliance.

Segmentation-oriented insights explaining how sample type nuances, diverse end users, distinct product types, and varied applications drive differentiated product strategies and commercialization choices

Understanding segmentation is essential to identify product priorities, tailor go-to-market approaches, and focus R&D investments across the biological sample collection kits space. Based on sample type, the market encompasses Blood, Saliva, Stool, Tissue, and Urine; Blood itself is further delineated into Plasma, Serum, and Whole Blood, and Tissue is subdivided into FFPE tissue, Fresh tissue, and Frozen tissue. These distinctions matter because preservation chemistry, container design, and downstream processing requirements vary significantly by specimen type, leading manufacturers to develop specialized substrates and stabilization approaches for nucleic acids, proteins, and viable cells.

Based on end user, the market serves Biopharma companies, Diagnostic laboratories, Home healthcare, Hospitals, and Research institutes. Each end user segment imposes distinct performance, regulatory, and supply requirements: clinical diagnostic laboratories prioritize standardized chain-of-custody and compatibility with automated extraction platforms; biopharma customers emphasize lot consistency and documentation to support clinical trials; home healthcare and patient-directed models demand user-friendly instructions and strong preservative performance at ambient temperatures; hospitals require integration with clinical workflows and hospital supply systems; and research institutes seek flexibility and cost-effective bulk formats for exploratory studies.

Based on product type, the market offers Automated systems, Multi sample kits, and Single use kits. Automated systems integrate with laboratory instrumentation to improve throughput and reduce hands-on time, while multi sample kits enable batch processing and cost efficiencies for high-volume settings. Single use kits are often optimized for point-of-care or single-visit patient sampling where contamination control and ease of disposal are priorities. Finally, based on application, use cases include Clinical diagnostics, Drug discovery, Environmental monitoring, Genetic testing, and Infectious disease testing, each of which imposes distinct analytical sensitivity, preservation, and chain-of-custody expectations. These cross-segment variances shape innovation roadmaps, commercial targeting, and regulatory strategies for manufacturers and buyers alike.

Regional strategic perspectives emphasizing how regulatory regimes, logistics realities, and clinical adoption patterns differ across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics influence nearly every strategic decision for manufacturers and distributors of biological sample collection kits. In the Americas, demand drivers include consolidated clinical laboratory networks, advanced home testing adoption, and a focus on fast-cycle clinical trials that require robust cold-chain logistics and high regulatory standards. North American procurement practices emphasize supplier validation, extended documentation, and integration with large laboratory information systems, encouraging suppliers to demonstrate interoperability and enterprise-grade quality controls.

In Europe, Middle East & Africa, regulatory harmonization efforts coexist with heterogeneous national requirements, which creates both opportunities and complexity for market entry. Manufacturers operating in this region must balance pan-regional strategies with localized compliance and distribution models. The regulatory emphasis on traceability and patient data privacy has prompted investments in secure digital tracking and localized quality documentation, while diverse infrastructure conditions across countries mean that ambient-stable solutions can offer competitive advantages in certain markets.

In Asia-Pacific, rapid expansion of diagnostics capacity and the growth of decentralized testing models are driving demand for adaptable kit formats and scalable manufacturing. Competitive pressure and cost sensitivity in several markets encourage local partnerships and contract manufacturing arrangements. Logistics networks and regulatory frameworks are evolving quickly, requiring agile market access strategies and a nuanced understanding of country-level regulatory authorities. Across all three regions, the interplay of regulatory requirements, distribution infrastructure, and clinical adoption rates determines which product attributes will resonate most strongly with buyers.

Key competitive patterns and company-level strategies showing how platform approaches, strategic partnerships, regulatory readiness, and targeted M&A are shaping industry positioning and differentiation

Competitive dynamics in the biological sample collection kits sector are defined by a mix of technology differentiation, quality systems maturity, and commercial scale. Leading organizations invest in platform approaches that allow modular adaptation across sample types and applications, enabling them to support clinical diagnostics, research studies, and decentralized testing with common core components. This platform mentality reduces time to market for new kit variants while allowing for economies in procurement and manufacturing.

Partnerships and vertical integration are emerging as common strategic responses to market complexity. Companies are forming alliances with logistics providers, reagent suppliers, and digital solution vendors to offer end-to-end sample-to-lab workflows that reduce friction for end users. At the same time, strategic acquisitions focused on niche capabilities-such as ambient-stability chemistries or advanced barcoding systems-are being used to fill portfolio gaps and accelerate product differentiation.

Quality and regulatory readiness remain market entry barriers that sustain advantage for established firms with audited manufacturing sites, ISO certifications, and comprehensive documentation practices. New entrants often focus on a narrow application or user segment to prove performance before broadening their commercial footprint. Finally, commercial approaches are bifurcating between enterprise sales models that emphasize laboratory integration and smaller, nimble go-to-market teams that focus on home healthcare and direct-to-consumer channels, each requiring distinct sales, training, and post-sales support capabilities.

Actionable strategic steps for leaders to fortify supply chains, integrate patient-centric design, streamline regulatory readiness, and calibrate commercial models for sustained advantage

Industry leaders should pursue a coordinated set of actions to strengthen resilience, differentiate products, and accelerate go-to-market impact. First, integrate human factors and digital support into product design to enhance self-collection success rates and reduce pre-analytical error; incorporating mobile-guided workflows and clear visual instructions can materially improve sample quality and user confidence. Second, prioritize qualification of diverse suppliers and nearshoring options to reduce exposure to tariff-driven cost volatility and logistics bottlenecks, while maintaining rigorous incoming inspection and supplier scorecarding practices to ensure consistency.

Third, invest in regulatory and quality infrastructure that supports rapid evidence generation and cross-jurisdictional approvals; standardized documentation templates and robust lot release testing can shorten approval timelines and improve buyer confidence. Fourth, align commercialization models with end user needs by offering integrated solutions for large laboratory systems and simplified, consumer-oriented kits for home healthcare channels, ensuring that training, technical support, and returns policies are optimized for each segment. Fifth, deploy scenario-planning and contractual flexibility to respond to policy changes, including options for bonded warehousing, tariff classification review, and contingent sourcing contracts that can be activated if trade conditions change.

Finally, establish a cross-functional commercialization playbook that links R&D, regulatory, supply chain, and commercial teams to speed decision-making and close the loop between field feedback and product iterations. These steps collectively will help organizations preserve product quality, protect margin, and capture emerging opportunities in a rapidly evolving landscape.

Robust mixed-methods research approach detailing expert interviews, documentary review, triangulation techniques, and validation safeguards used to ensure analytical rigor and reliability

The study's findings are grounded in a multi-method research framework that combines primary qualitative inputs with rigorous secondary sources and validation processes. Primary research included structured interviews with subject matter experts across manufacturing, laboratory operations, procurement, and regulatory affairs, enabling the capture of operational nuances and firsthand perspectives on product performance and commercial dynamics. These interviews informed hypothesis development and were used to probe real-world constraints such as cold-chain logistics, sample stability concerns, and user experience barriers.

Secondary research entailed systematic review of peer-reviewed literature, regulatory guidance documents, and public filings to contextualize technological trends, quality standards, and policy shifts. Data triangulation methods were applied to reconcile insights from different sources and to surface consistent themes across evidence streams. Throughout the process, quality controls included validation checks with independent experts, cross-referencing of technical claims against regulatory documentation, and iterative refinement of findings to remove ambiguities.

The methodology emphasizes transparency in assumptions, reproducibility of analytic steps, and traceability of qualitative inputs. Where applicable, sensitivity analyses and scenario-based assessments were used to explore the operational implications of supply chain disruptions and policy shifts, with results framed as strategic considerations rather than numerical projections. This approach ensures that the report's conclusions are actionable, defensible, and grounded in a combination of practitioner insight and documentary evidence.

Concise synthesis of core findings emphasizing the interplay of innovation, operational resilience, segmentation strategy, and regional differentiation that determines competitive success

The conclusion synthesizes the study's central themes: product innovation is being driven by analytical requirements and patient-centric delivery models; supply chain resilience and regulatory readiness are now core strategic priorities; segmentation nuances materially affect product design and commercialization choices; and regional dynamics require tailored market access and distribution approaches. Taken together, these threads point to a market environment where technical differentiation and operational excellence are both critical to long-term success.

Organizations that successfully align design, manufacturing, and commercial processes will be better positioned to withstand policy shifts and logistics disruptions while capturing opportunities in decentralized testing and specialized clinical applications. Conversely, firms that neglect supplier diversification, human factors, and regulatory robustness risk diminished product performance and slower market adoption. The balance of these risks and opportunities suggests that cross-functional agility, thoughtful segmentation strategies, and deliberate regional playbooks will be the primary determinants of competitive advantage.

In closing, stakeholders should treat the insights in this study as a strategic roadmap for aligning investments, partnerships, and operational practices with the evolving needs of laboratories, clinicians, and end users. By focusing on quality, usability, and resilient supply chains, organizations can both protect existing revenue streams and create pathways to new service models and clinical applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of smartphone-enabled barcoding and real-time tracking in sample collection kits to enhance chain of custody
  • 5.2. Rising demand for noninvasive saliva and breath sampling kits in point-of-care diagnostic applications in remote settings
  • 5.3. Development of ambient temperature stable reagents and transport media to simplify global sample logistics and reduce cold chain reliance
  • 5.4. Adoption of modular microfluidic platforms in collection kits for multiplexed biomarker separation and stabilization at source
  • 5.5. Use of artificial intelligence algorithms in pre-analytical quality control to detect sample contamination or insufficient volume before shipping
  • 5.6. Expansion of DIY at-home genetic testing kits with simplified user interfaces and integrated e-commerce replenishment options

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Sample Collection Kits Market, by Sample Type

  • 8.1. Blood
    • 8.1.1. Plasma
    • 8.1.2. Serum
    • 8.1.3. Whole Blood
  • 8.2. Saliva
  • 8.3. Stool
  • 8.4. Tissue
    • 8.4.1. FFPE Tissue
    • 8.4.2. Fresh Tissue
    • 8.4.3. Frozen Tissue
  • 8.5. Urine

9. Biological Sample Collection Kits Market, by End User

  • 9.1. Biopharma Companies
  • 9.2. Diagnostic Laboratories
  • 9.3. Home Healthcare
  • 9.4. Hospitals
  • 9.5. Research Institutes

10. Biological Sample Collection Kits Market, by Product Type

  • 10.1. Automated Systems
  • 10.2. Multi Sample Kits
  • 10.3. Single Use Kits

11. Biological Sample Collection Kits Market, by Application

  • 11.1. Clinical Diagnostics
  • 11.2. Drug Discovery
  • 11.3. Environmental Monitoring
  • 11.4. Genetic Testing
  • 11.5. Infectious Disease Testing

12. Biological Sample Collection Kits Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biological Sample Collection Kits Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biological Sample Collection Kits Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Thermo Fisher Scientific Inc.
    • 15.3.2. Danaher Corporation
    • 15.3.3. Becton Dickinson and Company
    • 15.3.4. Abbott Laboratories
    • 15.3.5. F. Hoffmann-La Roche AG
    • 15.3.6. bioMerieux SA
    • 15.3.7. Qiagen N.V.
    • 15.3.8. Greiner Bio-One International GmbH
    • 15.3.9. Copan Diagnostics Inc.
    • 15.3.10. PerkinElmer, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BIOLOGICAL SAMPLE COLLECTION KITS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BIOLOGICAL SAMPLE COLLECTION KITS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOLOGICAL SAMPLE COLLECTION KITS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. GCC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GCC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GCC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)